Skip to main content
“Transforming Care and Inspiring Hope for all children…”

News (Archive)

For Toddlers Allergic to Peanuts, a Tiny Bit of Protein Therapy Under the Tongue Could Be The Best Approach

October 13, 2023
A clinical study led by Edwin Kim, MD, at the UNC School of Medicine, showed how Peanut Sublingual Immunotherapy (Peanut SLIT) is safe and effective in children ranging from 1-to-4 years of age. Remission of peanut allergy was also possible after three months of stopping the treatment. A three-year clinical...

12 Months of Treatment with EPIT Superior to Placebo in Desensitizing Children to Peanuts

May 11, 2023
The study, called EPITOPE, led by senior author A. Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, and contributing author Edwin Kim, MD, MS, associate professor of pediatrics in the Division of Pediatric Allergy and Immunology at the UNC School of Medicine, shows...

Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease

April 3, 2023
Michael Kappelman, MD, MPH, was the lead PI on the clinical trial, which followed nearly 300 children with Crohn’s to evaluate how their conditions changed in response to anti-TNF biologic treatments alone or in combination with a second immune suppressive medication. CHAPEL HILL, N.C. – Crohn’s disease is a lifelong inflammatory...

Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

March 2, 2023
A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children. A four-year phase 2 clinical trial demonstrated that a peanut allergy treatment called sublingual immunotherapy,...

Ian Davis Awarded $1 Million by V Foundation

January 23, 2023
The V Foundation Board of Directors and Scientific Advisory Board has awarded funding to Ian Davis, MD, PhD, the G. Denman Hammond Professor of Childhood Cancer in the Division of Hematology/Oncology and a UNC Lineberger Comprehensive Cancer Center member, for his research project, “Novel mechanisms to improve CAR-T cell therapy for pediatric solid...